David Gill

About

David Gill is a Chartered Accountant and Chief Financial Officer of Juvenescence, a longevity-focused biotech company that develops and invests in therapies targeting age-related diseases. Before becoming CFO, he served as Group Controller at Juvenescence; earlier he was Head of Finance at Silence Therapeutics in London and previously spent 10 years at PwC. Public evidence places him on the finance and capital-markets side of the longevity ecosystem, but not as a documented personal investor.

Areas of interest